WebBNTX Stock Summary. BIONTECH SE's market capitalization of $31,779,622,876 is ahead of 92.61% of US-listed equities. BNTX's current price/earnings ratio is 3.14, which is higher than only 4.15% of US stocks with positive earnings. With a year-over-year growth in debt of -46.62%, BIONTECH SE's debt growth rate surpasses only 6.07% of about US ... WebApr 11, 2024 · View BioNTech SE Sponsored ADR BNTX investment & stock information. Get the latest BioNTech SE Sponsored ADR BNTX detailed stock quotes, stock data, …
BNTX -- Is Its Stock Price A Worthy Investment? Learn More.
WebWhile we make every effort to provide you the most accurate and up-to-date information about our products, please note that actual products may differ slightly from … WebApr 11, 2024 · 13 analysts have issued twelve-month price targets for BioNTech's shares. Their BNTX share price forecasts range from $130.00 to $260.00. On average, they … scrum hr certification
BioNTech SE - ADR (BNTX) Price & News - Google Finance
Web2024-10-10. Description. BioNTech SE is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens ... WebMar 6, 2024 · View BioNTech SE - ADR (BNTX) stock price today, market news, streaming charts, forecasts and financial information from FX Empire. WebJul 19, 2024 · MAINZ, Germany & Santa Monica, USA, July 19, 2024 – BioNTech SE (Nasdaq: BNTX, “BioNTech”) and Kite, a Gilead Company (Nasdaq: GILD, “Kite”) today announced the two companies have entered into a purchase agreement for BioNTech to acquire Kite’s solid tumor neoantigen T cell receptor (TCR) R&D platform and clinical … scrum how is velocity measured